Lymphogranuloma Venereum

Lymphogranuloma Venereum is a topic covered in the 5-Minute Emergency Consult.

To view the entire topic, please or .

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

-- The first section of this topic is shown below --

Basics

Description

  • Sexually transmitted disease
  • Primary stage (not always seen):
    • Painless papule, pustule, or ulcer
  • Secondary stage:
    • Spread to regional lymph nodes
    • Fluctuant inguinal lymphadenopathy (buboes)
    • Lymphadenopathy may be unilateral or bilateral
  • Responsive to antibacterial therapy
  • Tertiary stage:
    • If untreated, significant tissue damage and destruction may result
  • Endemic in Southeast Asia, Latin America, parts of Africa, and the Caribbean
  • Now endemic among men who have sex with men (MSM) in industrialized countries
  • Also known as:
    • Struma
    • Tropical bubo
    • Nicolas–Favre–Durand disease

Etiology

Chlamydia trachomatis serotypes L1, L2, and L3

-- To view the remaining sections of this topic, please or --

Basics

Description

  • Sexually transmitted disease
  • Primary stage (not always seen):
    • Painless papule, pustule, or ulcer
  • Secondary stage:
    • Spread to regional lymph nodes
    • Fluctuant inguinal lymphadenopathy (buboes)
    • Lymphadenopathy may be unilateral or bilateral
  • Responsive to antibacterial therapy
  • Tertiary stage:
    • If untreated, significant tissue damage and destruction may result
  • Endemic in Southeast Asia, Latin America, parts of Africa, and the Caribbean
  • Now endemic among men who have sex with men (MSM) in industrialized countries
  • Also known as:
    • Struma
    • Tropical bubo
    • Nicolas–Favre–Durand disease

Etiology

Chlamydia trachomatis serotypes L1, L2, and L3

There's more to see -- the rest of this entry is available only to subscribers.